ZombieHealthcare
What Happened to Jasper Therapeutics?
Ticker: JSPRSPAC Year: 2019
Return
-88.1%
Current Price
$15
Peak Price
$188.8
Trust Size
$57M
Summary
Jasper Therapeutics is a clinical-stage biotechnology company developing targeted therapies for mast cell-driven diseases. The company went public via SPAC merger with Amplitude Healthcare Acquisition Corp in 2021.
What Happened
Amplitude Healthcare Acquisition Corp merged with Jasper Therapeutics in 2021. The biotech company has advanced its anti-KIT antibody programs and has a price target of ~$26 from analysts. Jasper was misclassified as bankrupt and is actively trading on Nasdaq.
Timeline
2019-11-08
S-1 Registration Filed
Risk Indicators
â ïļ Reverse Split